# Mylan Laboratories Limited (FDF-2) - Inspection Records

Source: https://www.keypedia.com/companies/mylan-laboratories-limited-fdf-2/1bcb64f5-f3f2-412e-81da-b3efab26f310

> Inspection records and compliance data for Mylan Laboratories Limited (FDF-2) in Aurangabad, None. Access full analysis and detailed observations.

---

## Details

- Name: Mylan Laboratories Limited (FDF-2)
- FEI Number: 3008316970
- City: Aurangabad
- State: None
- Country Name: India
- Address Line 1: H-12 & H-13 Midc, Waluj
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK

## Related Documents

- [FDA Inspection 1253435 - Mylan Laboratories Limited (FDF-2) - 2023-02-03](https://www.keypedia.com/records/fda_inspections/mylan-laboratories-limited-fdf-2/c86b2c6d-3939-43ca-9c49-3ab1f5c1b33f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 3, 2023
- [FDA Inspection 1122884 - Mylan Laboratories Limited (FDF-2) - 2020-02-28](https://www.keypedia.com/records/fda_inspections/mylan-laboratories-limited-fdf-2/da22dd0f-6306-46da-8000-97facc10196d) — classification: No Action Indicated (NAI), source: FDA, date: February 28, 2020
- [FDA Inspection 1091217 - Mylan Laboratories Limited (FDF-2) - 2019-04-26](https://www.keypedia.com/records/fda_inspections/mylan-laboratories-limited-fdf-2/42de1dba-0b73-460b-9dc0-5c883cb0d514) — classification: No Action Indicated (NAI), source: FDA, date: April 26, 2019
- [FDA Inspection 1012796 - Mylan Laboratories Limited (FDF-2) - 2017-05-26](https://www.keypedia.com/records/fda_inspections/mylan-laboratories-limited-fdf-2/c3b3d8ef-b5cf-4868-ab95-1933bf124403) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 26, 2017
- [FDA Inspection 884211 - Mylan Laboratories Limited (FDF-2) - 2014-05-16](https://www.keypedia.com/records/fda_inspections/mylan-laboratories-limited-fdf-2/53ebc2c6-eeb9-4b2d-8a99-ac4237992fe3) — classification: No Action Indicated (NAI), source: FDA, date: May 16, 2014
- [FDA Inspection 775616 - Mylan Laboratories Limited (FDF-2) - 2012-03-09](https://www.keypedia.com/records/fda_inspections/mylan-laboratories-limited-fdf-2/fff7282c-5b9b-4473-9f22-67a98b04d40c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2012

## Related Companies

- [Combe Laboratories, Inc.](https://www.keypedia.com/companies/combe-laboratories-inc/165d44db-fdc0-4975-af22-35ec39c2735d)
- [Orion Corporation, Orion Pharma](https://www.keypedia.com/companies/orion-corporation-orion-pharma/bc21b600-e8f7-4570-9285-d3c41399fd82)
- [Penn Pharmaceutical Services Limited](https://www.keypedia.com/companies/penn-pharmaceutical-services-limited/0568bf3c-6deb-4f8f-9174-a7ff34c80343)
- [Haleon US Holdings LLC](https://www.keypedia.com/companies/haleon-us-holdings-llc/03c10541-23fe-4547-ae02-c47669f35343)
- [Delpharm Huningue S.A.S.](https://www.keypedia.com/companies/delpharm-huningue-sas/abe67002-072d-48fc-8ace-21b8021482f7)
- [Haupt Pharma Wuelfing GmbH](https://www.keypedia.com/companies/haupt-pharma-wuelfing-gmbh/34339ef4-fb2f-4297-ae5d-191a6adb86b0)
- [Orion Corporation, Orion Pharma](https://www.keypedia.com/companies/orion-corporation-orion-pharma/afdfe2db-9213-4d8d-84c3-4627195bb4c7)
- [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/66fdfcfe-6173-4e09-abb4-df089ede2996)
- [P & L Development LLC](https://www.keypedia.com/companies/p-l-development-llc/eed180a2-666b-448a-a387-2ddc3e1e9d91)
- [S.s.s. Company (international)](https://www.keypedia.com/companies/sss-company-international/f322f704-186a-434c-83d2-9468fed1ae6e)